Previous sessionNext session Epidemiology of hepatitis C among people who use drugs — Data to inform future planning Insights zone 3 (I3) In programme Wednesday, 23 October, 2019 - 15:00 to 16:30 View presentations Chair SypsaVana National and Kapodistrian University of AthensGreece StoneJack University of BristolUnited Kingdom Tracks The future of hepatitis C among people who inject drugs: new frontiers for policy, practice and science Keywords Infectious diseasesPublic healthBasic scienceTreatment: medical/pharmacologicalHarm reductionVulnerable groups Presentations Plenary session Poster session Big debate Structured session Workshop Oral presentation session Short communication session Poster guided tour Wednesday, 23 October 15:00 Oral presentation The contribution of injecting drug use as a risk factor for Hepatitis C virus transmission globally, regionally, and at country level: a modelling study 15:00 to 15:15 Insights zone 3 (I3) Adam Trickey 15:15 Oral presentation Factors associated with HIV and hepatitis C in the context of routes of drug administration among problem drug users in Latvia, 2018 15:15 to 15:30 Insights zone 3 (I3) Laura Isajeva 15:45 Oral presentation HCV care in an opiate substitution therapy program: assessment of infection, liver-related damage, and treatment rates. 15:45 to 16:00 Insights zone 3 (I3) Roberto Muga 16:00 Oral presentation Slamming, drug injection in sexual contexts: increased HIV and HCV exposure for MSM points to a need for intersectional approaches to harm reduction 16:00 to 16:15 Insights zone 3 (I3) Marie Jauffret-Roustide 16:15 Oral presentation Hepatitis C virus reinfection following antiviral treatment among people who inject drugs: a systematic review and meta-analysis 16:15 to 16:30 Insights zone 3 (I3) Jason Grebely